TherapeuticsMD
TXMD
TXMD
42 hedge funds and large institutions have $3.09M invested in TherapeuticsMD in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
+1
Holders Change %
+2.44%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
7
Closed
4
Calls
$14K
Puts
$2K
Net Calls
+$12K
Net Calls Change
+$2K
Top Buyers
| 1 |
TSS
Two Sigma Securities
New York
|
+$12.2K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.94K |
| 3 |
Renaissance Technologies
New York
|
+$2.41K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$769 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$672 |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$125K |
| 2 |
TC
Tejara Capital
London,
United Kingdom
|
-$46.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.22K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.7K |
| 5 |
Morgan Stanley
New York
|
-$1.09K |
